Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer

Published:2019-06 Issue: Volume:164 Page:17-22
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Khoshakhlagh Mahdieh,Soleimani Atena,Binabaj Maryam Moradi,Avan Amir,Ferns Gordon A.,Khazaei Majid,Hassanian Seyed Mahdi

Funder

Mashhad University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference63 articles.

1. Molecular characterization and targeted therapeutic approaches in breast cancer;Toss;Breast Cancer Res.,2015

2. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics;McPherson;BMJ (Clinical Research Ed.),2000

3. Breast cancer statistics, 2013;DeSantis;CA Cancer J. Clin.,2014

4. The therapeutic potential of PI3K/Akt/mTOR inhibitors in breast cancer: rational and progress;Bahrami;J. Cell. Biochem.,2018

5. Biomarker analysis in CLEOPATRA: searching for a sensitive prognostic factor in breast cancer;Avan;J. Clin. Oncol.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between hedgehog signaling pathway and the complex tumor microenvironment in breast cancer: current knowledge and therapeutic promises;Cell Communication and Signaling;2024-09-09

2. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities;Mutation Research - Reviews in Mutation Research;2024-07

3. Organic phosphate but not inorganic phosphate regulates Fgf23 expression through MAPK and TGF-ꞵ signaling;iScience;2024-06

4. HOLOTHURIA SCABRA METHANOL EXTRACT INHIBITS CANCER GROWTH THROUGH TGF-β/PI3K/PTEN SIGNALING PATHWAY IN BREAST CANCER MICE MODEL;Experimental Oncology;2024-05-31

5. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions;Recent Patents on Anti-Cancer Drug Discovery;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3